IndraLab
Statements
Lipopolysaccharide inhibits RIPK1. 6 / 6
|
6
reach
"Further studies demonstrated that LPS stimulation of RIPK1-deficient monocytes resulted in increased necroptosis (inflammatory cell death) and IL-1β release; this has also been observed in animal models.As with RELA haploinsufficiency, the proinflammatory clinical features of RIPK1 deficiency result from reduced cell viability; however, there is additional release of a potent inflammatory mediator."